These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 23528488)
1. [Vasobral in the treatment of brain lesions: views of physicians and patients]. Kamchatnov PR Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):23-5. PubMed ID: 23528488 [TBL] [Abstract][Full Text] [Related]
2. [The influence of alpha-dihydroergocryptine derivatives on psychomotor manifestations in Parkinson disease]. Sadekov RA Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):43-5. PubMed ID: 11195537 [TBL] [Abstract][Full Text] [Related]
3. [Assessment of quality of life and treatment adherence in patients with dizziness treated with vasobral]. Lebedeva AV; Kamchatnov PR; Burd SG; Prikazchikov SV; Cherkasova AE; Solovyeva TY Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2):28-34. PubMed ID: 30874523 [TBL] [Abstract][Full Text] [Related]
4. [Preventive treatment of migraine with vasobral: a multicenter trial]. Tabeeva GR; Azimova IuE Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):26-30. PubMed ID: 21389936 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of the combination drug vasobral in chronic vascular encephalopathy]. Levin OS; Barantsevich ER; Belskaya GN; Vasenina EE; Kopishinskaya SV; Lukashevich IG; Ostroumova OD; Psokhina OV; Radiuk MA Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):25-9. PubMed ID: 25591512 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of cerebrovascular insufficiency. A trial of orphol in 8940 patients by 800 medical practitioners (author's transl)]. Kukwa L MMW Munch Med Wochenschr; 1981 Feb; 123(8):310-4. PubMed ID: 6783887 [TBL] [Abstract][Full Text] [Related]
7. [Vasobral and stabilized cerebral vascular complication: hemodynamic and psychometric study]. Poncin-Lafitte M; Migeon P; Rancurel G; Rapin JR Ann Radiol (Paris); 1987; 30(6):425-30. PubMed ID: 3129979 [No Abstract] [Full Text] [Related]
8. [The use of vasobral in patients with chronic cerebrovascular disorders]. Kamchatnov PR Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):70-2. PubMed ID: 22500318 [No Abstract] [Full Text] [Related]
9. [Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy]. Shprakh VV; Molokov DD; Tatarinova MB; Burdukovskaia NL Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):39-40. PubMed ID: 8754338 [No Abstract] [Full Text] [Related]
10. [Experience in the administration of vasobral in sensorineural vascular hypoasusis]. Grinshteĭn AB; Shnaĭder NA; Kromm OK; Pavlovskaia MV Vestn Otorinolaringol; 2001; (2):39-41. PubMed ID: 11338557 [TBL] [Abstract][Full Text] [Related]
11. [Use of vasobral in therapy of central nervous system pathology in children of early age]. Zaĭtseva IN Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):92-4. PubMed ID: 20614656 [No Abstract] [Full Text] [Related]
12. [On the encephalotrophic action of hydergine. Clinical study]. Garagnani Sciarretta B; Rimondini S; Martelli A Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406 [No Abstract] [Full Text] [Related]
13. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)]. Bugrova SG; Novikov AE Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503 [TBL] [Abstract][Full Text] [Related]
14. [Card-Hydergin for treatment of heart insufficiency in elderly patients with cerebrovascular deficiency]. Schmidt W ZFA (Stuttgart); 1977 Mar; 53(8):447-52. PubMed ID: 324165 [No Abstract] [Full Text] [Related]
15. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)]. Biel ML; Seus R; Struppler A Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665 [TBL] [Abstract][Full Text] [Related]
16. [Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes]. Ordosgoitia H; Castro C; Carbayeda M; Labella T An Otorrinolaringol Ibero Am; 1989; 16(3):271-9. PubMed ID: 2502041 [TBL] [Abstract][Full Text] [Related]
17. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice]. Kohler H Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670 [No Abstract] [Full Text] [Related]
18. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents]. Szobor A; Klein M; Bräuer H MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511 [No Abstract] [Full Text] [Related]
19. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine]. Cosmi F; Caresia L; Panebianco G Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528 [No Abstract] [Full Text] [Related]
20. [Treatment of cerebral wasting diseases with Card-Hydergin]. Liebhart M Med Welt; 1976 Nov; 76(48):2341-6. PubMed ID: 794620 [No Abstract] [Full Text] [Related] [Next] [New Search]